安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Homepage - RAPT Therapeutics
RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by our mission to treat inflammatory and immunologic diseases Our cutting-edge science is fully focused on developing therapeutics that intelligently target key drivers of the immune system to transform the treatment of inflammatory and immunologic diseases, and improve and empower countless lives Join us in our quest
- About Us - RAPT Therapeutics
RAPT Therapeutics is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunologic diseases Utilizing our deep and proprietary expertise in immunology, we develop novel molecules that are designed to modulate the critical immune responses underlying these diseases Our
- Pipeline - RAPT Therapeutics
RAPT Therapeutics is focused on the development of therapies for patients with significant unmet needs in inflammatory and immunologic diseases Utilizing our deep and proprietary expertise in immunology, we are developing novel molecules that are designed to modulate the critical immune responses underlying these diseases
- Science - RAPT Therapeutics
Our proprietary drug discovery and development engine has identified several immune drivers that have the ability to be “tuned down” to suppress an overactive immune response in inflammatory diseases These include immunoglobulin E (IgE) as well as the surface receptor CCR4 We are working to develop drugs that target these drivers; these drugs will potentially […]
- Press Releases - RAPT Therapeutics, Inc.
RAPT on track to initiate trial this year SOUTH SAN FRANCISCO, Calif , Sept 29, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living
- RAPT Therapeutics Announces $150 Million Private Placement
RAPT Therapeutics is a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing therapies for patients with significant unmet needs in inflammatory diseases
- RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial . . .
RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results March 07, 2024 Company maintains solid cash position of $158 9 million SOUTH SAN FRANCISCO, Calif , March 07, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies
- RAPT Therapeutics Deepens Expertise in Allergic Diseases with . . .
RAPT Therapeutics is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases
|
|
|